Journal
EUROPEAN NEUROPSYCHOPHARMACOLOGY
Volume 33, Issue -, Pages 101-116Publisher
ELSEVIER
DOI: 10.1016/j.euroneuro.2020.01.015
Keywords
Alzheimer's disease; Histones (H2B and H3); Histone acetyltransferase (CBP, PCAF); Histone deacetylase (HDAC1, HDAC2 and HDAC3); F2 area of frontal cortex; Hippocampus
Funding
- CNRS [UMR7364]
- University of Strasbourg
- ANR [ANR-12-MALZ-0002-01]
- France Alzheimer (AAP SM 2017) [1664]
- Alsace Alzheimer 67 association
- France Alzheimer
Ask authors/readers for more resources
Memory impairment is the main feature of Alzheimer's disease (AD). Initial impairments originate in the temporal lobe area and propagate throughout the brain in a sequential manner. Epigenetic mechanisms, especially histone acetylation, regulate plasticity and memory processes. These may be dismantled during the disease. The aim of this work was to establish changes in the acetylation-associated pathway in two key brain regions affected in AD: the hippocampus and the F2 area of frontal cortex in end-stage AD patients and age-matched controls. We found that the F2 area was more affected than the hippocampus. Indeed, CREB-Binding Protein (CBP), P300/CBP-associated protein (PCAF), Histone Deacetylase 1 (HDAC1) and HDAC2 (but not HDAC3) levels were strongly decreased in F2 area of AD compared to controls patients, whereas only HDAC1 was decreased and CBP showed a downward trend in the hippocampus. At the histone level, we detected a substantial increase in total (H3 and H2B) histone levels in the frontal cortex, but these were decreased in nuclear extracts, pointing to a dysregulation in hi-stone trafficking/catabolism in this brain region. Histone H3 acetylation levels were increased in cell nuclei mainly in the frontal cortex. These findings provide evidence for acetylation dysfunctions at the level of associated enzymes and of histones in AD brains, which may under-lie transcriptional dysregulations and AD-related cognitive impairments. They further point to stronger dysregulations in the F2 area of the frontal cortex than in the hippocampus at an end-stage of the disease, suggesting a differential vulnerability and/or compensatory mechanisms efficiency towards epigenetic alterations. (c) 2020 Elsevier B.V. and ECNP. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available